Literature DB >> 3940521

Sensitization of cancer chemotherapeutic agents by nitroheterocyclics.

D W Siemann, R T Mulcahy.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3940521     DOI: 10.1016/0006-2952(86)90567-8

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  7 in total

1.  The in situ tumour response to combinations of cyclophosphamide and tirapazamine.

Authors:  D W Siemann
Journal:  Br J Cancer Suppl       Date:  1996-07

2.  Sensitization of C6 glioma to carboplatin cytotoxicity by hyperthermia and thymidine.

Authors:  J D Cohen; H I Robins; M J Javid
Journal:  J Neurooncol       Date:  1990-08       Impact factor: 4.130

Review 3.  Modulation of the tumor vasculature and oxygenation to improve therapy.

Authors:  Dietmar W Siemann; Michael R Horsman
Journal:  Pharmacol Ther       Date:  2015-06-11       Impact factor: 12.310

Review 4.  The role of glutathione in radiation and drug induced cytotoxicity.

Authors:  J B Mitchell; A Russo
Journal:  Br J Cancer Suppl       Date:  1987-06

5.  Enhancement of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) toxicity by acetohydroxamic acid analogues of 3-nitropyrazole in vitro.

Authors:  R T Mulcahy; D J Wustrow; R R Hark; A S Kende
Journal:  Invest New Drugs       Date:  1987       Impact factor: 3.850

6.  Potentiation of CCNU activity by misonidazole in metastases.

Authors:  D W Siemann; K L Alliet
Journal:  Clin Exp Metastasis       Date:  1987 Jan-Mar       Impact factor: 5.150

7.  Phase I/pharmacokinetic/biochemical study of the nitroimadazole hypoxic cell sensitiser SR2508 (etanidazole) in combination with cyclophosphamide.

Authors:  P J O'Dwyer; F P LaCreta; J Walczak; T Cox; S Litwin; J P Hoffman; M Zimny; R L Comis
Journal:  Br J Cancer       Date:  1993-10       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.